التفاصيل البيبلوغرافية
| العنوان: |
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial |
| المؤلفون: |
Tweed, Conor D *, Dawson, Rodney, Burger, Divan A, Conradie, Almari, Crook, Angela M, Mendel, Carl M, Conradie, Francesca, Diacon, Andreas H, Ntinginya, Nyanda E, Everitt, Daniel E, Haraka, Frederick, Li, Mengchun, van Niekerk, Christo H, Okwera, Alphonse, Rassool, Mohammed S, Reither, Klaus, Sebe, Modulakgotla A, Staples, Suzanne, Variava, Ebrahim, Spigelman, Melvin |
| المصدر: |
In The Lancet Respiratory Medicine December 2019 7(12):1048-1058 |
| قاعدة البيانات: |
ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder